Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLungCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLungCancerTeam Member asked a question 💭
Manteca, CA

Stage 3B, due to location of the tumor it can not be removed. Can immunotherapy. Shrink and remove the 5 centimeter tumor

March 10
 · 
Reactions
A MyLungCancerTeam Member

What is considered hog PDL protein

March 10
MyLungCancerTeam

Can immunotherapy shrink a 5 cm stage 3B lung cancer tumor that can't be surgically removed?

Yes, immunotherapy can help shrink or control stage 3B lung cancer tumors that cannot be surgically removed. For stage 3B non-small cell lung cancer, surgery typically isn't recommended because the cancer has often spread too far Show Full Answer

Can immunotherapy shrink a 5 cm stage 3B lung cancer tumor that can't be surgically removed?

Yes, immunotherapy can help shrink or control stage 3B lung cancer tumors that cannot be surgically removed. For stage 3B non-small cell lung cancer, surgery typically isn't recommended because the cancer has often spread too far to be removed completely.

Instead, doctors often use immunotherapy combined with other treatments like chemotherapy and radiation therapy to help shrink or control the cancer. Immunotherapy works by helping your immune system recognize and attack cancer cells that would otherwise hide from it.

For stage 3A and beyond, immunotherapy is specifically used when surgery, chemotherapy, and/or radiation cannot be performed or when someone isn't healthy enough for those treatments. The goal is to activate your immune system to fight the tumor cells.

While immunotherapy can be effective, it's important to know that it works well in about 20 to 50 percent of advanced non-small cell lung cancer cases. When it does work, the response is typically strong and can improve overall survival.

Your oncologist may test your tumor for PD-L1 protein levels and T cells, as immunotherapy tends to work best in tumors with higher levels of these markers.

March 10

Related Questions

View All
A MyLungCancerTeam Member asked a question 💭
Raymore, MO

A MyLungCancerTeam Member asked a question 💭
Vallejo, CA